Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9FON

Cocrystal structure of Drosophila melanogaster TDO with a bound compound

This is a non-PDB format compatible entry.
Summary for 9FON
Entry DOI10.2210/pdb9fon/pdb
DescriptorTryptophan 2,3-dioxygenase, PROTOPORPHYRIN IX CONTAINING FE, (~{R})-(7-chloranylimidazo[1,5-a]pyridin-5-yl)-(1-phenyl-1,2,3-triazol-4-yl)methanol, ... (4 entities in total)
Functional Keywordsinhibitor, heme, oxidoreductase
Biological sourceDrosophila melanogaster (fruit fly)
Total number of polymer chains2
Total formula weight88493.81
Authors
Wicki, M.,Mac Sweeney, A. (deposition date: 2024-06-12, release date: 2025-04-23, Last modification date: 2025-10-22)
Primary citationCren, S.,Lotz-Jenne, C.,Kimmerlin, T.,Pothier, J.,Risch, P.,Mac Sweeney, A.,Joesch, C.,Pouzol, L.,Chavanton-Arpel, A.,Boss, C.
Cellular Potency Optimization of Novel Heme-Binding Imidazo[5,1- b ]thiazoles, Imidazo[1,5- a ]pyridines and Pyrazines as Potent IDO1 Inhibitors Devoid of Cytochrome P450 Inhibition.
J.Med.Chem., 68:20130-20153, 2025
Cited by
PubMed Abstract: Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase 2 (TDO2) are key enzymes in the kynurenine pathway of the catabolism of the essential amino acid tryptophan. Both enzymes actively contribute to the immunosuppressive microenvironment in many types of cancer. Selective or dual inhibition of these enzymes could, therefore, be beneficial in combination with other immunotherapies such as immune-checkpoint therapy. In a fragment-based approach, we optimized fragment into a series of potent imidazo[5,1-]thiazole, imidazo[1,5-]pyridine and pyrazine IDO1 inhibitors. The introduction of the triazole side chain resulted in a reduced enzyme-to-cell potency shift for IDO1 inhibition, albeit at the expense of TDO2 potency, and allowed the discovery of potent and cellular active IDO1 inhibitors. Moreover, despite the propensity of the imidazole motif to inhibit cytochrome P450 enzymes (CYP), we were able to discover potent IDO1 inhibitors devoid of CYP inhibition. Imidazo[1,5-]pyrazine has an overall suitable profile, which warrants further investigation.
PubMed: 41002114
DOI: 10.1021/acs.jmedchem.5c01067
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.121 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon